Institutional shares held 65,000
0 calls
0 puts
Total value of holdings $114K
$0 calls
$0 puts
Market Cap $6.75M
2,873,960 Shares Out.
Institutional ownership 2.26%
# of Institutions 1

Quarterly Institutional Activity in BBI

Shares Bought
Shares Sold
View Transactions

Latest Institutional Activity in BBI

Top Purchases

Q1 2024
Old Point Trust & Financial Services N A Shares Held: 44 ($77.4)
Q3 2023
Jbf Capital, Inc. Shares Held: 295K ($519K)
Q3 2023
Gts Securities LLC Shares Held: 50.1K ($88.2K)
Q3 2023
Virtu Financial LLC Shares Held: 43.6K ($76.7K)
Q3 2023
Geode Capital Management, LLC Shares Held: 41.4K ($73K)

Top Sells

Q3 2023
Tower Research Capital LLC (Trc) Shares Held: 10.2K ($18K)
Q2 2023
Cubist Systematic Strategies, LLC Shares Held: 10.1K ($17.8K)
Q1 2023
Vanguard Group Inc Shares Held: 23.1K ($40.6K)
Q1 2023
Millennium Management LLC Shares Held: 20.9K ($36.8K)
Q1 2023
Bank Of America Corp Shares Held: 2 ($3.52)

About BBI

Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the treatment of autoimmune and inflammatory diseases; and BBI-10, a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases, as well as next-generation kinase inhibitors. It has license and collaboration agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. The company was founded in 2009 and is headquartered in Boulder, Colorado.


Insider Transactions at BBI

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
514K Shares
From 1 Insiders
Open market or private purchase 514K shares
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on BBI

Follow Brickell Biotech, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBI shares.

Notify only if
Any

Insider Trading

Get notified when an Brickell Biotech, Inc. insider buys or sells BBI shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Brickell Biotech, Inc.

Track Activities on BBI